RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes.

Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes.

Add to Collection
2005 Oct Observational studies Fist_Author_Year_PM

Full Author : ['Rosak, C', 'Petzoldt, R', 'Wolf, R', 'Reblin, T', 'Dehmel, B', 'Seidel, D']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2005
Cited by : Not Available

This study investigated the efficacy during daily practice of rosiglitazone (RSG) added to metformin (MET) in poorly controlled type 2 diabetes mellitus. Two post-marketing observational studies were conducted in Germany over 6 months. RSG (4 mg/day titra.....

Keywords : ["rosiglitazone plus metformin", "large observational study", "clinical practice result", "well tolerate", "type diabetes", "people", "effective"]